BridgeBio Interview Guide

BridgeBio is a pioneering biopharmaceutical company founded in 2015, with a mission to discover, create, test, and deliver transformative medicines for patients afflicted by genetic diseases and cancers that have identifiable genetic drivers. The company effectively connects advancements in genetic science from academic institutions to the practical development of impactful therapies, managing a robust portfolio of over 20 drug development programs spanning therapeutic areas such as genetic dermatology, precision oncology, and cardiology, including two approved drugs. With its headquarters located in San Francisco, and additional offices in Palo Alto, Raleigh, Montreal, and Zurich, BridgeBio is committed to scientific excellence and rapid execution in translating contemporary discoveries into future medicines. The company fosters a culture centered on patient welfare, ethical standards, and a firm commitment to diversity, equity, and inclusion, creating a collaborative and dynamic environment for its employees to thrive.